Modeling the architecture and dynamics of hematopoiesis

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 2, Issue 2, 2010, Pages 235-244

  Dingli, David ^a   Pacheco, Jorge M ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MAMMALIA;

CYTOKINE;

BIOLOGICAL MODEL; CELL DIFFERENTIATION; CYTOLOGY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; PHYSIOLOGY; REVIEW;

CELL DIFFERENTIATION; CYTOKINES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; MODELS, BIOLOGICAL;

EID: 79952117829     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.56     Document Type: Article

References (79)

1. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A 1994, 91:9857-9860.
2. Kondo M, Wagers AJ,ManzMG, Prohaska SS, Scherer DC, et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol 2003, 21:759-806.
3. McCulloch EA, Till JE. Proliferation of hemopoietic colony-forming cells transplanted into irradiated mice. Radiat Res 1964, 22:383-397.
4. McCulloch EA, Till JE. Perspectives on the properties of stem cells. Nat Med 2005, 11:1026-1028.
5. Morrison SJ, Uchida N, Weissman IL. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol 1995, 11:35-71.
6. Mackey MC. Cell kinetic status of haematopoietic stem cells. Cell Prolif 2001, 34:71-83.
7. Haurie C, Dale DC, Mackey MC. Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models. Blood 1998, 92:2629-2640.
8. Haurie C, Dale DC, Mackey MC. Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic, and cyclical neutropenic patients before and during treatment with G-CSF. Exp Hematol 1999, 27:401-409.
9. Haurie C, Dale DC, Rudnicki R, Mackey MC. Modeling complex neutrophil dynamics in the grey collie. J Theor Biol 2000, 204:505-519.
10. Haurie C, Person R, Dale DC, Mackey MC. Hematopoietic dynamics in grey collies. Exp Hematol 1999, 27:1139-1148.
11. Colijn C, Mackey MC. A mathematical model of hematopoiesis: II. Cyclical neutropenia. J Theor Biol 2005, 237:133-146.
12. Colijn C, Mackey MC. A mathematical model of hematopoiesis-I. Periodic chronic myelogenous leukemia. J Theor Biol 2005, 237:117-132.
13. Shochat E, Stemmer SM, Segel L. Human haematopoiesis in steady state and following intense perturbations. Bull Math Biol 2002, 64:861-886.
14. Schmitz S, Franke H, Loeffler M, Wichmann HE, Diehl V. Model analysis of the contrasting effects of GM-CSF and G-CSF treatment on peripheral blood neutrophils observed in three patients with childhood-onset cyclic neutropenia. Br J Haematol 1996, 95:616-625.
15. Schmitz S, Loeffler M, Jones JB, Lange RD, Wichmann HE. Synchrony of bone marrow proliferation and maturation as the origin of cyclic haemopoiesis. Cell Tissue Kinet 1990, 23:425-442.
16. Wichmann HE, Loeffler M, Herkenrath P, Gerhardts MD, Wesselborg C, et al. Mathematische modelle in der haematologie. Klinische Wochenschrift (Springer) 1983, 61:935-940.
17. Foley C, Mackey MC. Dynamic hematological disease: a review. J Math Biol 2009, 58:285-322.
18. Santillan M, Mahaffy JM, Belair J, Mackey MC. Regulation of platelet production: the normal response to perturbation and cyclical platelet disease. J Theor Biol 2000, 206:585-603.
19. Mahaffy JM, Belair J, Mackey MC. Hematopoietic model with moving boundary condition and state dependent delay: applications in erythropoiesis. J Theor Biol 1998, 190:135-146.
20. Mackey MC,Dormer P. Continuous maturation of proliferating erythroid precursors. Cell Tissue Kinet 1982, 15:381-392.
21. Belair J, Mackey MC,Mahaffy JM. Age-structured and two-delaymodels for erythropoiesis. Math Biosci 1995, 128:317-346.
22. Mackey MC, Aprikyan AA, Dale DC. The rate of apoptosis in post mitotic neutrophil precursors of normal and neutropenic humans. Cell Prolif 2003, 36:27-34.
23. Foley C, Mackey MC. Mathematical model for G-CSF administration after chemotherapy. J Theor Biol 2009, 257:27-44.
24. Abkowitz JL, Catlin SN, Guttorp P. Evidence that hematopoiesis may be a stochastic process in vivo. Nat Med 1996, 2:190-197.
25. Gordon MY, Blackett NM. Route to repopulation- a unification of the stochastic model and separation of stem-cell subpopulations. Leukemia 1994, 8:1068-1072, discussions 1072-1063.
26. Dingli D, Traulsen A, Pacheco JM. Compartmental architecture and dynamics of hematopoiesis. PLoS ONE 2007, 2(:):e345.
27. Quesenberry PJ, Kittler E, Lowry P, Crittenden R. Stromal regulation of hemopoiesis and the role of subliminal growth factor production. Leukemia 1993, 7(suppl 2):S3-S4.
28. Steensma DP, Harrison CN, Tefferi A. Hydroxyureaassociated platelet count oscillations in polycythemia vera: a report of four new cases and a review. Leuk Lymphoma 2001, 42:1243-1253.
29. Spangrude GJ, Smith L, Uchida N, Ikuta K, Heimfeld S, et al. Mouse hematopoietic stem cells. Blood 1991, 78:1395-1402.
30. Lemischka IR, Raulet DH, Mulligan RC. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 1986, 45:917-927.
31. Abkowitz JL, Catlin SN, McCallie MT, Guttorp P. Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. Blood 2002, 100:2665-2667.
32. Gordon MY, Lewis JL, Marley SB. Of mice and men. and elephants. Blood 2002, 100:4679-4680.
33. McCarthy KF. Population size and radiosensitivity of murine hematopoietic endogenous long-term repopulating cells. Blood 1997, 89:834-841.
34. McCarthy KF. Marrow frequency of rat long-term repopulating cells: evidence that marrow hematopoietic stem cell concentration may be inversely proportional to species body weight. Blood 2003, 101:3431-3435.
35. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4:7-25.
36. McKenzie JL, Gan OI, Doedens M, Wang JC, Dick JE. Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment. Nat Immunol 2006, 7:1225-1233.
37. Abkowitz JL, Linenberger ML, Newton MA, Shelton GH, Ott RL, et al. Evidence for the maintenance of hematopoiesis in a large animal by the sequential activation of stem-cell clones. Proc Natl Acad Sci U S A 1990, 87:9062-9066.
38. Dingli D, Traulsen A, Michor F. (A)symmetric stem cell replication and cancer. PLoS Comput Biol 2007, 3(:):e53.
39. Dingli D, Traulsen A, Pacheco JM. Stochastic dynamics of hematopoietic tumor stem cells. Cell Cycle 2007, 6:441-446.
40. Traulsen A, Pacheco JM, Dingli D. On the origin of multiple mutant clones in paroxysmal nocturnal hemoglobinuria. Stem Cells 2007, 25:3081-3084.
41. Abkowitz JL, Persik MT, Shelton GH, Ott RL, Kiklevich JV, et al. Behavior of hematopoietic stem cells in a large animal. Proc Natl Acad Sci U S A 1995, 92:2031-2035.
42. Huxley JS. Problems of relative growth. New York: Dial Press; 1932.
43. Thompson DW, Bonner JT. On growth and form. New York: Cambridge University Press; 1992.
44. West GB,WoodruffWH, Brown JH. Allometric scaling of metabolic rate from molecules and mitochondria to cells and mammals. Proc Natl Acad Sci U S A 2002, 99(suppl 1):2473-2478.
45. Dingli D, Pacheco JM. Allometric scaling of the active hematopoietic stem cell pool across mammals. PLoS ONE 2006, 1(:):e2.
46. Buescher ES, Alling DW, Gallin JI. Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J Clin Invest 1985, 76:1581-1584.
47. Nash R, Storb R, Neiman P. Polyclonal reconstitution of human marrow after allogeneic bone marrow transplantation. Blood 1988, 72:2031-2037.
48. Dingli D, Pacheco JM. Ontogenic growth of the haemopoietic stem cell pool in humans. Proc Biol Sci 2007, 274:2497-2501.
49. Rufer N, Brummendorf TH, Kolvraa S, Bischoff C, Christensen K, et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999, 190:157-167.
50. Lopes JV, Pacheco JM, Dingli D. Acquired hematopoietic stem cell disorders and mammalian size. Blood 2007, 110:4137-4139.
51. Goldman JM. Chronic myeloid leukemia-still a few questions. Exp Hematol 2004, 32:2-10.
52. Tefferi A. Polycythemia vera: a comprehensive review and clinical recommendations. Mayo Clin Proc 2003, 78:174-194.
53. Luzzatto L, Bessler M, Rotoli B. Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell 1997, 88:1-4.
54. Massey GV, Zipursky A, Chang MN, Doyle JJ, Nasim S, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood 2006, 107:4606-4613.
55. Tricot G, Mecucci C, Van den Berghe H. Evolution of the myelodysplastic syndromes. Br J Haematol 1986, 63:609-614.
56. Zipursky A. Transient leukaemia-a benign form of leukaemia in newborn infants with trisomy 21. Br J Haematol 2003, 120:930-938.
57. Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood 1998, 92:3362-3367.
58. Dingli D, Luzzatto L, Pacheco JM. Neutral evolution in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A 2008, 105:18496-18500.
59. Marley SB, Lewis JL, Gordon MY. Progenitor cells divide symmetrically to generate new colony-forming cells and clonal heterogeneity. Br J Haematol 2003, 121:643-648.
60. Donohue DM, Reiff RH, Hanson ML, Betson Y, Finch CA. Quantitative measurement of the erythrocytic and granulocytic cells of the marrow and blood. J Clin Invest 1958, 37:1571-1576.
61. Finch CA, Harker LA, Cook JD. Kinetics of the formed elements of human blood. Blood 1977, 50:699-707.
62. Cronkite EP, Fliedner TM. Granulocytopoiesis.NEngl J Med 1964, 270:1347-1352.
63. Araten DJ, Nafa K, Pakdeesuwan K, Luzzatto L. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci U S A 1999, 96:5209-5214.
64. Parker C, Omine M, Richards S, Nishimura J, Bessler M, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005, 106:3699-3709.
65. Araten DJ, Luzzatto L. The mutation rate in PIGA is normal in patients with paroxysmal nocturnal hemoglobinuria (PNH). Blood 2006, 108:734-736.
66. Dingli D, Pacheco JM, Traulsen A. Multiple mutant clones in blood rarely coexist. Phys Rev E Stat Nonlin Soft Matter Phys 2008, 77:021915.
67. Dingli D, Traulsen A, Pacheco JM. Chronic myeloid leukemia: origin, development, response to therapy and relapse. Clin Leuk 2008, 2:133-139.
68. Dingli D, Antal T, Traulsen A, Pacheco JM. Progenitor cell self-renewal and cyclic neutropenia. Cell Prolif 2009, 42(3):330-338.
69. Dingli D, Traulsen A, Pacheco JM. Dynamics of haemopoiesis across mammals. Proc Biol Sci 2008, 275:2389-2392.
70. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961, 25:585-621.
71. Shepherd BE, Kiem HP, Lansdorp PM, Dunbar CE, Aubert G, et al. Hematopoietic stem cell behavior in non-human primates. Blood 2007, 110:1806-1813.
72. Pacheco JM, Traulsen A, Antal T, Dingli D. Cyclic neutropenia in mammals. Am J Hematol 2008, 83:920-921.
73. Michor F, Hughes TP, Iwasa Y, Branford S, Shah NP, et al. Dynamics of chronic myeloid leukaemia. Nature 2005, 435:1267-1270.
74. Roeder I, Horn M, Glauche I, Hochhaus A, Mueller MC, et al. Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications. Nat Med 2006, 12:1181-1184.
75. Brummendorf TH, Mak J, Sabo KM, Baerlocher GM, Dietz K, et al. Longitudinal studies of telomere length in feline blood cells: implications for hematopoietic stem cell turnover in vivo. Exp Hematol 2002, 30:1147-1152.
76. Marley SB, Deininger MW, Davidson RJ, Goldman JM, Gordon MY. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia. Exp Hematol 2000, 28:551-557.
77. Horwitz MS, Duan Z, Korkmaz B, Lee H-H, Mealiffe ME, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 2007, 109:1817-1824.
78. Hillmen P, Hows JM, Luzzatto L. Two distinct patterns of glycosylphosphatidylinositol (GPI) linked protein deficiency in the red cells of patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1992, 80:399-405.
79. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995, 333:1253-1258.